Table 2 Comparison of clinical, demographic characteristics and quality of life between patients with and without insomnia
Patients with insomnia (ISI > 7) (n = 12) | Patients without insomnia (ISI ≤ 7) (n = 16) | p | |
|---|---|---|---|
Age (years) | 22 (18–26) | 27 (22–33) | 0.62 |
Sex (M/F) | 6 (50%)/6 (50%) | 12 (75%)/4 (25%) | 0.24 |
BMI (kg/m2) | 21 (20–25) | 22 (20–26) | 0.98 |
Anxiolytic (n = 27) | 2 (17%) | 0 (0%) | 0.18 |
Screen time (h/day) | 7 (5–8) | 5 (4–8) | 0.74 |
Coffee intake (cups/day) | 0 (0–2) | 1 (1–2) | 0.36 |
Tea intake (cups/day) | 0 (0–1) | 1 (0–1) | 0.41 |
Alcohol intake (g/day) | 0 (0–1) | 0 (0–3) | 0.73 |
Shift work | 0 (0%) | 2 (13%) | 0.49 |
Insomnia Severity Index | |||
ISI score | 14 (13–18) | 3 (3–5) | < 0.0001 |
Pittsburgh Sleep Quality Index | |||
PSQI score | 9 (7–12) | 3 (3–4) | < 0.0001 |
PSQI > 5 | 11 (92%) | 2 (13%) | < 0.0001 |
Morningness-Eveningness Questionnaire | |||
MEQ score | 49 (41–57) | 55 (52–62) | 0.03 |
Morning type | 2 (17%) | 6 (38%) | 0.40 |
Neither type | 6 (50%) | 10 (62%) | 0.70 |
Evening type | 4 (33%) | 0 (0%) | 0.02 |
Epworth Sleepiness scale | |||
ES score | 5 (5–9) | 5 (4–6) | 0.55 |
ES score > 10 | 1 (8%) | 0 (0%) | 0.43 |
Numeric rating scale for pain (n = 22) | 3 (1–4) | 0 (0–1) | < 0.05 |
Berlin scale | |||
Berlin score | 1 (0–2) | 0 (0–1) | 0.07 |
Berlin > 1 | 4 (33%) | 1 (6%) | 0.13 |
Restless Legs Syndrome | 5 (42%) | 0 (0%) | < 0.01 |
IRLS score | 0 (0–13) | 0 (0–0) | < 0.05 |
0 ≤ IRLS score ≤ 10 (mild RLS) | 0 (0%) | 0 (0%) | 1.00 |
11 ≤ IRLS score ≤ 40 (moderate to very severe RLS) | 5 (42%) | 0 (0%) | < 0.01 |
Hospital Anxiety Depression scale | |||
Anxiety HAD score | 9 (8–11) | 4 (3–6) | < 0.0001 |
Anxiety HAD score > 7 | 9 (75%) | 1 (6%) | < 0.001 |
Depression HAD score | 7 (5–10) | 1 (1–4) | < 0.001 |
Depression HAD score > 7 | 5 (42%) | 0 (0%) | < 0.01 |
CFQ-R score | |||
Physical functioning | 52 (29–79) | 83 (75–92) | < 0.05 |
Vitality | 42 (25–42) | 67 (50–83) | < 0.001 |
Emotional functioning | 64 (40–73) | 93 (87–100) | < 0.001 |
Eating problems | 89 (67–100) | 100 (89–100) | 0.20 |
Treatment burden | 67 (44–78) | 78 (56–89) | 0.24 |
Health perception | 56 (33–67) | 67 (56–78) | < 0.05 |
Social functioning | 61 (39–67) | 83 (78–94) | < 0.01 |
Body image | 56 (33–67) | 78 (67–89) | < 0.001 |
Role limitations | 71 (58–75) | 92 (92–100) | < 0.001 |
Weight problems | 67 (33–100) | 67 (33–100) | 0.98 |
Respiratory symptoms | 56 (56–78) | 78 (67–94) | < 0.05 |
Digestive symptoms | 78 (67–89) | 89 (89–100) | < 0.05 |